دورية أكاديمية
How might the Trans-Pacific Partnership impact on the pharmaceutical sector in Vietnam?
العنوان: | How might the Trans-Pacific Partnership impact on the pharmaceutical sector in Vietnam? |
---|---|
المؤلفون: | Binh NH; Daitin & Associates, 19 Hoang Dieu, Dist. 4, Ho Chi Minh City, Vietnam., Anh PN; Master of Law course S1580107, Major in Economic Law, Law Department, University of Economics and Law, Vietnam National University, 6 Quarter, Linh Trung Ward, Thu Duc District, Ho Chi Minh City, Vietnam., Phuong NM; Ho Chi Minh City University of Food Industry, 140 Le Trong Tan, Tan Phu Dist., Ho Chi Minh City, Vietnam. |
المصدر: | Pharmaceutical patent analyst [Pharm Pat Anal] 2016 Jul; Vol. 5 (4), pp. 261-70. Date of Electronic Publication: 2016 Jun 27. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Future Science Country of Publication: England NLM ID: 101582615 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2046-8962 (Electronic) Linking ISSN: 20468954 NLM ISO Abbreviation: Pharm Pat Anal Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: London : Future Science, 2012- |
مواضيع طبية MeSH: | Commerce* , Drug Industry* , Patents as Topic*, Drugs, Generic ; International Cooperation ; Vietnam |
مستخلص: | Ratification of the Trans-Pacific Partnership (TPP) will attract a large number of foreign drug companies in the coming years to Vietnam. It is anticipated to bring investment to Vietnam's pharmaceutical industries, lead to increased infrastructure and enable the use of more sophisticated technologies for the discovery, development and manufacture of drugs. However, with respect to pharmaceutical companies, which are producing generic drugs primarily, the availability of biologic will be reduced. Thus, the consequence is, an increase in drug cost resulting in difficulties for patients wishing to procure these drugs. This will be particularly detrimental for developing countries, such as Vietnam and Malaysia. |
فهرسة مساهمة: | Keywords: TPP; TRIPS; brand name; data exclusivity; drugs; generic; industry; market; patent; pharmaceuticals |
المشرفين على المادة: | 0 (Drugs, Generic) |
تواريخ الأحداث: | Date Created: 20160628 Date Completed: 20170313 Latest Revision: 20170313 |
رمز التحديث: | 20240628 |
DOI: | 10.4155/ppa-2016-0008 |
PMID: | 27346326 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!